CAMX ETF holdings (NYSE) | MetaTrader

チャート全体を表示 Full chart

概要全保有資産ヒートマップ

主要保有銘柄 Market Value Shares Weight %

ELV ELEVANCE HEALTH, INC. 3.3018 M 9 550.0000 5.1494%

HON HONEYWELL INTERNATIONAL INCORPORATION 3.2062 M 14.0920 K 5.0003%

UBER UBER TECHNOLOGIES, INC. 3.0739 M 38.4000 K 4.7940%

MDT MEDTRONIC PUBLIC LIMITED COMPANY 2.7143 M 26.3630 K 4.2332%

CME CME GROUP INC. 2.6466 M 9 156.0000 4.1276%

TXN TEXAS INSTRUMENTS INCORPORATED 2.5866 M 12.0000 K 4.0340%

UNP UNION PACIFIC CORPORATION 2.5861 M 11.0000 K 4.0332%

NXPI NXP Semiconductors N.V. 2.5400 M 11.2320 K 3.9613%

BMY BRISTOL-MYERS SQUIBB COMPANY 2.4645 M 44.7680 K 3.8435%

Nintendo Co., Ltd. 2.4432 M 158.6500 K 3.8103%

MAS MASCO CORPORATION 2.4295 M 36.7600 K 3.7889%

A

AMRZ Amrize AG 2.3611 M 44.8700 K 3.6822%

ALGN ALIGN TECHNOLOGY, INC. 2.3186 M 14.2220 K 3.6160%

LH LABCORP HOLDINGS INC. 2.2107 M 8 142.0000 3.4478%

SHIMANO INC. 2.1449 M 188.9800 K 3.3451%

GOOGL ALPHABET INC. 2.1051 M 6 228.0000 3.2830%

ABNB AIRBNB, INC. 2.0597 M 15.9210 K 3.2122%

E

ET ENERGY TRANSFER LP 2.0480 M 111.0000 K 3.1939%

DAL DELTA AIR LINES, INC. 2.0189 M 30.6400 K 3.1486%

DEO DIAGEO PLC 1.8950 M 20.4200 K 2.9553%

1
2

ニュース

カムルス、第4四半期の収益予想を下回り、2026年の見通しを引き下げ

Camurus reports Q4 revenue miss, lowers 2026 outlook

カムルスの先端巨大症治療薬オクライズ、FDAが再申請を受理

FDA accepts Camurus’ resubmission for acromegaly treatment Oclaiz

カムルスの2025年第3四半期：売上高18%増も見通し下方修正で株価下落

Camurus Q3 2025 slides: Revenue up 18% but stock dips on lowered guidance

カムルス、Buvidalの販売不振により2025年の収益予想を下方修正

Camurus cuts 2025 revenue forecast as Buvidal sales miss estimates

カムルス、2025年第2四半期に52%の収益急増と主要な規制上のマイルストーンを達成

Camurus Q2 2025 slides reveal 52% revenue surge and key regulatory milestones

Earnings call transcript: Camurus AB Q2 2025 earnings beat expectations

Camurus Q2 2025 slides: Record revenue and profit amid product portfolio expansion